Medication prices are surging in Iran and some treatments have become difficult to find as a US blockade and intensified sanctions squeeze the country's pharmaceutical industry. Iranians are stocking up on food and medicines amid fears of dire shortages, with families struggling to afford essential medications.
Employer-sponsored health insurance premiums are projected to see their largest single-year increase in 20 years in 2027, rising 11% and approaching a nearly four-fold increase since the start of the century. The rising costs are affecting workers and healthcare professionals alike, with some providers going without coverage.
The World Health Organization has updated its contraceptive guidelines to recommend a wider range of safe and effective options, including emergency contraception, longer-lasting implants, and future contraceptives for men. The expansion aims to give people more choices that meet their individual needs.
The Department of Health and Human Services announced an unprecedented cancellation of health insurance for 760,000 individuals enrolled in Affordable Care Act marketplace plans, marking the first time the agency has taken such action.
Clinical trials for major diseases are experiencing a critical shortage of participants, with only 7% of adult cancer patients in the U.S. enrolling in trials and Alzheimer's treatment studies facing similar global recruitment challenges despite new drug developments.
Vaccination coverage for children has fallen across the US and European Union since the COVID-19 pandemic, with Michigan reporting its highest exemption rate in over a decade and EU countries reversing progress made since 1980. Access issues persist as updated COVID-19 vaccines remain unavailable through a key federal program covering half of US children.
A bipartisan campaign founded by philanthropists Olivia and Tom Walton announced a $100 million, 5-year commitment to make giving birth in the United States safer and reduce maternal mortality rates by half.
A first-of-its-kind analysis by KFF of new federal data revealed significant variation in how health insurers handle prior authorization requests across Medicare Advantage, Medicaid managed care, and ACA marketplace plans, with at least one in eight standard requests denied last year.
The Trump administration is reinstating a policy that would allow immigration officers to deny green cards to applicants who use public benefits such as Medicaid, food stamps, housing vouchers, or other safety net programs. The rule reverses a 2022 Biden-era policy and governs how officials apply the 'public charge' test in immigration decisions.
Starting July 1, 2026, Medicare will cover select GLP-1 weight loss medications for approximately $50 through a Trump administration pilot program, marking the first time the federal program has covered obesity drugs. The 18-month initiative raises concerns about potential drug shortages.
Family planning and health organizations in Pennsylvania have filed a lawsuit alleging that a new Trump administration policy could delay or deny federal funding to providers serving tens of thousands of patients across the state.
The Trump administration finalized major changes to Affordable Care Act exchanges, including significantly greater access to catastrophic health plans with high deductibles, raising concerns among insurance experts and healthcare stakeholders about coverage adequacy.
The U.S. Supreme Court on Thursday maintained access to the abortion pill mifepristone through telehealth and mail delivery, setting aside lower court restrictions while litigation over the drug continues. Mifepristone is used in more than 60% of U.S. abortions.
Hundreds of hospitals nationwide face potential closure following Medicaid cuts from the One Big Beautiful Bill Act, prompting state lawmakers to explore emergency loans and financial assistance programs to prevent healthcare access disruptions.
The Supreme Court heard oral arguments on a case involving 'skinny labeling' practices that have significant implications for generic drug availability and access, with justices appearing to signal the practice may survive legal challenge.
The Centers for Medicare & Medicaid Services and FDA announced a new pathway to streamline Medicare coverage for breakthrough medical devices, cutting red tape and providing predictability for device manufacturers and faster patient access to life-changing technologies.
